Skip to main content
. 2024 Apr 5;87(4):1003–1012. doi: 10.1021/acs.jnatprod.3c01288

Table 3. Anti-RSV Activity, Cytotoxicity for HEp-2 Cells, and Selectivity Indices (SI) of Compounds Isolated from Milletia oblata.

  anti-RSV activity cytotoxicity
SIb
compound/extract IC50 (μM) CC50 (μM) cytostatic activitya (CC50/IC50)
1 >100.0 >100.0   1.0
2 >100.0 >100.0   1.0
3 22.0 90.0   4.1
4 >100.0 >100.0   1.0
5 53 >100.0   >1.9
6 1.4 50.0 PCS (20.0 μM) 35.7
7 1.8 6.7   3.8
8 1.5 42.0 PCS (20.0 μM) 28.0
9 0.8 12.5 PCS (0.8 and 4.0 μM) 15.6
10 0.4 26.5 PCS (4.0 μM) 61.6
11 8.0 91.0 PCS (20.0 μM) 11.4
12 >100.0 >100   1.0
13 2.1 >100.0 PCS (4.0, 20.0, and 100.0 μM) >47.6
14 10.0 >100.0 PCS (100.0 μM) >10
15 10.0 65.0 PCS (20.0 μM) 6.5
16 >100.0 >100.0   1.0
17 >100.0 >100.0   1.0
18 NDc NDc NDc NDc
19 >0.8 2.0   <2.5
ribavirin 10.6 >100 PCP (100 μM) >9.4
DMSO >100 >100   1
a

The CC50 assay was complemented by microscopic recording of possible cytostatic activity of test compounds manifested as poor cell proliferation (PCP), altered cell shape (ACS), or poor cell staining (PCS).

b

SI of 1 indicates lack of antiviral activity, i.e., lack of cell protection against RSV; SI of 2–10 suggests that antiviral activity may at least in some compounds be unspecific due to cytostatic activity (poor cell proliferation/altered cell shape) that occurs at concentrations just below the CC50 and may not be detectable by the cell toxicity assay used; SI > 10 suggests specific antiviral activity for most compounds tested.

c

ND, not determined